BeOne Medicines Ltd. — Form 4
Filed July 14, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 59/100
What the filing says
Chief Executive Officer OYLER JOHN (ONC) sold 1.9M shares (~$44.6M) on the open market (80% of holdings). Large sale — ~80% of holdings.
Why this rating
Large sale — ~80% of holdings.
See more from July 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.